Contraceptives Market Growth, Future Prospects and Competitive Analysis, 2016-2022, the global contraceptives market was valued at USD 19.7 Bn in 2015, and is expected to reach USD 25.5 Bn by 2022, expanding at a CAGR of 3.6% from 2016 to 2022.
Browse Full Report Visit - http://www.acutemarketreports.com/report/contraceptives-market
Market Insights:
Contraception is defined as voluntary method of preventing pregnancy by altering fertilization, ovulation and intervention through drugs and devices. This report studies the current status and future prospects of the drugs and devices commercially available in the global contraceptives market. Temporary contraceptives are the most preferred contraception mode across the world. Some of the prime factors that drive the global contraceptives market are drive to avoid unintentional pregnancies and overcoming the risk of sexually transmitted infections. Growing awareness about productive health, and increased approvals for novel and highly effective female contraceptive solutions also drive the contraceptives market. Initiatives by governments and NGOs to promote the use of contraceptives and public concessions for the same are facilitating to growing demand for contraceptives.
Oral contraceptive pills is the largest product segment in the contraceptives market. Combined hormonal contraceptives are in high demand in the present market scenario, due to their high effectiveness and ease of use. Among the device types, intrauterine devices hold the largest market share demonstrating significant usage in developed markets and growing adoption in emerging markets of Asia-Pacific. Subdermal implants and female condoms have developed their niche in the developed regions of North America and Europe and their awareness is steadily increasing in Latin America and Asian markets.
North America is the largest market for contraceptives followed by Europe. High incidence of teenage and unintentional pregnancy and wide prevalence of sexually transmitted diseases are the major contributors to the dominance of these regions. On the other hand, novel contraceptive solutions such as implants, vaginal rings and others are in high demand in developed countries due to high disposable incomes and high awareness. Asia-Pacific is the most promising regional market for contraceptive drugs and devices. Government and NGO initiatives focusing on population control, prevention of unintentional pregnancies and sexually transmitted diseases in low income groups are responsible for the surge in demand for contraceptives in Asia-Pacific.
Contraception is defined as voluntary method of preventing pregnancy by altering fertilization, ovulation and intervention through drugs and devices. This report studies the current status and future prospects of the drugs and devices commercially available in the global contraceptives market. Temporary contraceptives are the most preferred contraception mode across the world. Some of the prime factors that drive the global contraceptives market are drive to avoid unintentional pregnancies and overcoming the risk of sexually transmitted infections. Growing awareness about productive health, and increased approvals for novel and highly effective female contraceptive solutions also drive the contraceptives market. Initiatives by governments and NGOs to promote the use of contraceptives and public concessions for the same are facilitating to growing demand for contraceptives.
Oral contraceptive pills is the largest product segment in the contraceptives market. Combined hormonal contraceptives are in high demand in the present market scenario, due to their high effectiveness and ease of use. Among the device types, intrauterine devices hold the largest market share demonstrating significant usage in developed markets and growing adoption in emerging markets of Asia-Pacific. Subdermal implants and female condoms have developed their niche in the developed regions of North America and Europe and their awareness is steadily increasing in Latin America and Asian markets.
North America is the largest market for contraceptives followed by Europe. High incidence of teenage and unintentional pregnancy and wide prevalence of sexually transmitted diseases are the major contributors to the dominance of these regions. On the other hand, novel contraceptive solutions such as implants, vaginal rings and others are in high demand in developed countries due to high disposable incomes and high awareness. Asia-Pacific is the most promising regional market for contraceptive drugs and devices. Government and NGO initiatives focusing on population control, prevention of unintentional pregnancies and sexually transmitted diseases in low income groups are responsible for the surge in demand for contraceptives in Asia-Pacific.
Browse All Reports of This Category - http://www.acutemarketreports.com/category/pharmaceutical-market
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
Chapter 2 Executive Summary
2.1 Contraceptives Market Share, by Drugs, 2015 (Value %)
2.2 Contraceptives Market, by Devices, 2015 (USD Mn)
2.3 Contraceptives Market Share, by Geography, 2015 (Value %)
2.1 Contraceptives Market Share, by Drugs, 2015 (Value %)
2.2 Contraceptives Market, by Devices, 2015 (USD Mn)
2.3 Contraceptives Market Share, by Geography, 2015 (Value %)
Chapter 3 Contraceptives Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.1 Competitive Analysis: Market Positioning, by Key Market Players
3.1 Introduction, Facts and Figures
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.1 Competitive Analysis: Market Positioning, by Key Market Players
Chapter 4 Global Contraceptives Market Analysis, by Drugs, 2014-2022 (USD Mn)
4.1 Preface
4.2 Contraceptive Pills
4.3 Injectable Contraceptives
4.4 Topical Contraceptives
4.1 Preface
4.2 Contraceptive Pills
4.3 Injectable Contraceptives
4.4 Topical Contraceptives
Chapter 5 Global Contraceptives Market Analysis, by Devices, 2014-2022 (USD Mn)
5.1 Preface
5.2 Male Condoms
5.3 Female Condoms
5.4 Diaphragms
5.5 Contraceptive Sponges
5.6 Vaginal Rings
5.7 Subdermnal Implants
5.8 Intrauterine Devices
5.1 Preface
5.2 Male Condoms
5.3 Female Condoms
5.4 Diaphragms
5.5 Contraceptive Sponges
5.6 Vaginal Rings
5.7 Subdermnal Implants
5.8 Intrauterine Devices
Chapter 6 Global Contraceptives Market, by Geography, 2014-2022 (USD Mn)
6.1 Preface
6.2 North America
6.2.1 U.S.
6.2.2 Canada
6.3 Europe
6.3.1 U.K.
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia-Pacific
6.4.1 Japan
6.4.2 China
6.4.3 Rest of Asia-Pacific
6.5 Middle East and Africa (MEA)
6.6 Latin America
6.1 Preface
6.2 North America
6.2.1 U.S.
6.2.2 Canada
6.3 Europe
6.3.1 U.K.
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia-Pacific
6.4.1 Japan
6.4.2 China
6.4.3 Rest of Asia-Pacific
6.5 Middle East and Africa (MEA)
6.6 Latin America
To Get Complete Report @ http://www.acutemarketreports.com/report/contraceptives-market
Chapter 7 Company Profiles
7.1 Teva Pharmaceutical Industries Limited
7.1.1 Business Description
7.1.2 Financial Health and Budget Allocation
7.1.3 Product Positions/Portfolio
7.1.4 News Coverage
7.2 Bayer HealthCare AG
7.2.1 Business Description
7.2.2 Financial Health and Budget Allocation
7.2.3 Product Positions/Portfolio
7.2.4 News Coverage
7.3 Actavis, Inc.
7.3.1 Business Description
7.3.2 Financial Health and Budget Allocation
7.3.3 Product Positions/Portfolio
7.3.4 News Coverage
7.4 Merck & Co., Inc.
7.4.1 Business Description
7.4.2 Financial Health and Budget Allocation
7.4.3 Product Positions/Portfolio
7.4.4 News Coverage
7.5 Church & Dwight, Co., Inc.
7.5.1 Business Description
7.5.2 Financial Health and Budget Allocation
7.5.3 Product Positions/Portfolio
7.5.4 News Coverage
7.6 CooperSurgical, Inc.
7.6.1 Business Description
7.6.2 Financial Health and Budget Allocation
7.6.3 Product Positions/Portfolio
7.6.4 News Coverage
7.7 Reckitt Benckiser plc
7.7.1 Business Description
7.7.2 Financial Health and Budget Allocation
7.7.3 Product Positions/Portfolio
7.1 Teva Pharmaceutical Industries Limited
7.1.1 Business Description
7.1.2 Financial Health and Budget Allocation
7.1.3 Product Positions/Portfolio
7.1.4 News Coverage
7.2 Bayer HealthCare AG
7.2.1 Business Description
7.2.2 Financial Health and Budget Allocation
7.2.3 Product Positions/Portfolio
7.2.4 News Coverage
7.3 Actavis, Inc.
7.3.1 Business Description
7.3.2 Financial Health and Budget Allocation
7.3.3 Product Positions/Portfolio
7.3.4 News Coverage
7.4 Merck & Co., Inc.
7.4.1 Business Description
7.4.2 Financial Health and Budget Allocation
7.4.3 Product Positions/Portfolio
7.4.4 News Coverage
7.5 Church & Dwight, Co., Inc.
7.5.1 Business Description
7.5.2 Financial Health and Budget Allocation
7.5.3 Product Positions/Portfolio
7.5.4 News Coverage
7.6 CooperSurgical, Inc.
7.6.1 Business Description
7.6.2 Financial Health and Budget Allocation
7.6.3 Product Positions/Portfolio
7.6.4 News Coverage
7.7 Reckitt Benckiser plc
7.7.1 Business Description
7.7.2 Financial Health and Budget Allocation
7.7.3 Product Positions/Portfolio
Latest Reports :
http://www.acutemarketreports.com/report/3d-bioprinters-market
http://www.acutemarketreports.com/report/3d-bioprinters-market
About - Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
Name : Chris Paul
ACUTE MARKET REPORTS
Designation : Global Sales Manager
Toll Free(US/CANADA): +1-855-455-8662
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com
Our Blog :- http://www.pdfdevices.com/
No comments:
Post a Comment